A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Current anticancer treatments essentially target the primary tumour cells that proliferate quickly, but do not effectively ...

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

I want to know if the risk of cancer increases with age. Goriola (by SMS) Our physical structure changes multiple times throughout the process of aging. The significant health change that occurs in ...

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

Typical cancer immunotherapies, for example, consist of a molecule or molecules from tumor cells (called antigens ... in ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Blocking the carrier could then starve these cancer cells of the energy they need to ... "This creates new opportunities for structure-based drug design in order to develop better, more targeted ...

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...